Bio Protocol vs Haedal Protocol — how do they compare? Bio Protocol trades at Rp514.67 (market cap Rp1,15T, Rp256,3M 24h volume), while Haedal Protocol trades at Rp289.89 (market cap Rp131,12M, Rp28,74M 24h volume). The key difference: Bio Protocol is far larger — about 8770.6× Haedal Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 454,2M / 1B HAEDAL (46%) for Haedal Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Haedal Protocol for 14 Days on average.
| BIO | HAEDAL | |
|---|---|---|
Market Cap | Rp1,15T | Rp131,12M |
Volume (24h) | Rp256,3M | Rp28,74M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 454,2M / 1B HAEDAL (46%) |
Typical Hold Time | 16 Days | 14 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Haedal is a leading liquid staking protocol built specifically on the Sui blockchain. It provides a reliable infrastructure that enables users to stake their SUI and Walrus tokens with validators, allowing them to earn ongoing consensus rewards. Additionally, users can unlock liquidity in the form of liquid staking tokens (LST), which can be utilized across decentralized finance (DeFi) applications. Haedal's goal is to become the primary platform for staking and earning within the Sui ecosystem.
Read more on HAEDAL →